These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

635 related items for PubMed ID: 26088619

  • 1. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
    Yamamoto A, Okada AA, Kano M, Koizumi H, Saito M, Maruko I, Sekiryu T, Iida T.
    Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
    [Abstract] [Full Text] [Related]

  • 2. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M, Shiraga F, Yamashita A, Shiragami C, Ono A, Shirakata Y, Kimura S, Shiode Y, Kawata T, Hosogi M, Fujiwara A, Morizane Y.
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [Abstract] [Full Text] [Related]

  • 3. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Hara C, Sawa M, Sayanagi K, Nishida K.
    Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
    [Abstract] [Full Text] [Related]

  • 4. Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T.
    Br J Ophthalmol; 2015 Sep; 99(9):1284-8. PubMed ID: 25777816
    [Abstract] [Full Text] [Related]

  • 5. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
    Saito M, Kano M, Itagaki K, Ise S, Imaizumi K, Sekiryu T.
    Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy.
    Cho HJ, Kim KM, Kim HS, Han JI, Kim CG, Lee TG, Kim JW.
    Am J Ophthalmol; 2016 May; 165():1-6. PubMed ID: 26921806
    [Abstract] [Full Text] [Related]

  • 7. Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.
    Ijiri S, Sugiyama K.
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):351-7. PubMed ID: 25023147
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y, Iwahashi C, Gomi F.
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T.
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT, Lai JC, Wee R, Yanagihara R, Shantha JG, Ayabe J, Hirai K.
    BMC Ophthalmol; 2016 Jul 27; 16():127. PubMed ID: 27465105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T, Gomi F, Sawa M, Tsujikawa M, Nishida K.
    Br J Ophthalmol; 2012 Mar 27; 96(3):394-9. PubMed ID: 21719568
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial.
    Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, Cheung GCM, Zhang Z, Leal S, Ishibashi T, PLANET Investigators.
    JAMA Ophthalmol; 2018 Jul 01; 136(7):786-793. PubMed ID: 29801063
    [Abstract] [Full Text] [Related]

  • 19. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
    Cho HJ, Baek JS, Lee DW, Cho SW, Kim CG, Kim JW.
    Retina; 2013 Jul 01; 33(10):2126-32. PubMed ID: 23609123
    [Abstract] [Full Text] [Related]

  • 20. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
    Sakai T, Ohkuma Y, Kohno H, Hayashi T, Watanabe A, Tsuneoka H.
    Br J Ophthalmol; 2014 Dec 01; 98(12):1642-8. PubMed ID: 25053762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.